Clover Health (CLOV) Home Care CEO sells 175,000 shares

Rhea-AI Filing Summary

Clover Health Investments executive Brady Patrick Priest, CEO of Home Care, reported an open-market sale of Class A Common Stock. On March 4, 2026, he sold 175,000 shares at a weighted average price of $2.17 per share, in multiple trades between $2.16 and $2.18.

After this transaction, Priest held 1,998,584 shares of Clover Health Class A Common Stock in direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Priest Brady Patrick

(Last) (First) (Middle)

C/O CLOVER HEATLH INVESTMENTS, CORP.

NOT APPLICABLE

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO of Home Care

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/04/2026		S		175,000	D	$2.17(1)	1,998,584	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/Peter J. Rivas as attorney-in-fact for Brady Priest	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CLOV executive Brady Patrick Priest report?

Brady Patrick Priest reported selling 175,000 shares of Clover Health Class A Common Stock. The sale occurred in open-market transactions at a weighted average price of $2.17 per share, reflecting routine insider trading activity disclosed for regulatory transparency.

At what prices did Brady Patrick Priest sell CLOV shares?

The 175,000 Clover Health shares were sold at a weighted average price of $2.17 per share. Individual trades occurred in multiple transactions at prices ranging from $2.16 to $2.18, as disclosed in the Form 4 footnote for additional pricing detail.

How many CLOV shares does Brady Patrick Priest hold after the sale?

After the reported open-market sale, Brady Patrick Priest directly holds 1,998,584 shares of Clover Health Class A Common Stock. This post-transaction balance is disclosed in the Form 4 as the amount of stock beneficially owned following the transaction.

What role does Brady Patrick Priest hold at Clover Health (CLOV)?

Brady Patrick Priest is identified as an officer of Clover Health, serving as CEO of Home Care. His officer status makes him a reporting person required to disclose transactions in Clover Health securities on Form 4 under applicable securities regulations.

Was the CLOV insider transaction a buy or a sell?

The reported insider transaction was a sale of Clover Health Class A Common Stock. The Form 4 lists transaction code “S” and describes it as an open-market sale, with 175,000 shares sold and no acquisitions or purchases reported in this filing.